336 related articles for article (PubMed ID: 8635461)
1. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
Schoneberg T; Yun J; Wenkert D; Wess J
EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.
Schöneberg T; Sandig V; Wess J; Gudermann T; Schultz G
J Clin Invest; 1997 Sep; 100(6):1547-56. PubMed ID: 9294123
[TBL] [Abstract][Full Text] [Related]
5. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
Bichet DG; Turner M; Morin D
Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
[TBL] [Abstract][Full Text] [Related]
8. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function.
Zhu X; Wess J
Biochemistry; 1998 Nov; 37(45):15773-84. PubMed ID: 9843382
[TBL] [Abstract][Full Text] [Related]
9. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
[TBL] [Abstract][Full Text] [Related]
11. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
Birnbaumer M; Gilbert S; Rosenthal W
Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
[TBL] [Abstract][Full Text] [Related]
13. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
Knoers NV; Deen PM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic diabetes insipidus.
Bichet DG
Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
[TBL] [Abstract][Full Text] [Related]
15. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.
Robben JH; Sze M; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F253-60. PubMed ID: 16926443
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Bernier V; Morello JP; Zarruk A; Debrand N; Salahpour A; Lonergan M; Arthus MF; Laperrière A; Brouard R; Bouvier M; Bichet DG
J Am Soc Nephrol; 2006 Jan; 17(1):232-43. PubMed ID: 16319185
[TBL] [Abstract][Full Text] [Related]
17. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
Szalai C; Molnár E; Sallay P; Czinner A
Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
[TBL] [Abstract][Full Text] [Related]
18. Molecular aspects of vasopressin receptor function.
Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J
Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
Bichet DG
Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
[TBL] [Abstract][Full Text] [Related]
20. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Inaba S; Hatakeyama H; Taniguchi N; Miyamori I
J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]